Amgen (NASDAQ:AMGN), a United States-based biopharmaceutical company, announced on Friday that it has increased its dividend for the first quarter of 2022.
The company has declared a dividend of USD1.94 per share for the first quarter of 2022, up 10% compared to the year-ago period.
The dividend will be paid to shareholders of record at 15 February 2022 on 8 March 2022.
Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.
Oxford Biomedica signs extended deal to make AstraZeneca COVID-19 vaccine
Eli Lilly and Company announces Q3 2022 dividend
Abbott announces quarterly common dividend
Sun Pharma reports FY22 full year results
Alcon to expand ophthalmic eye drop portfolio with acquisition of EYSUVIS